Skip to main content
OpenTrials

Clinical trial condition

Adult Growth Hormone Deficiency

Explore clinical trials studying Adult Growth Hormone Deficiency. Study availability and eligibility vary by location and protocol.

40 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Adult Growth Hormone Deficiency trial results

Completed

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

NCT01706783

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site København Ø, Denmark
  • Novo Nordisk Investigational Site Odense, Denmark
  • Novo Nordisk Investigational Site Stockholm, Sweden
View Trial Details
Completed

Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

NCT02229851

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 117 locations
View Trial Details
Completed

A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

NCT03075644

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Chiba-shi, Chiba, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
  • Novo Nordisk Investigational Site Kagoshima, Japan
View Trial Details
Completed

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

NCT02382939

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site København Ø, Denmark
  • Novo Nordisk Investigational Site Odense, Denmark
  • Novo Nordisk Investigational Site Angers, France
View all 28 locations
View Trial Details
Completed

MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

NCT01225666

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +11 more
Locations
  • Internal Clinic in University Hospital St. Anna Brno, Czechia
  • University Hospital, 2nd Department of Internal Medicine Hradec Králové, Czechia
  • State Health Center, 2nd department of internal medicine Budapest, Hungary
  • Semmelweis University, 2nd Clinic of Internal Medicine Budapest, Hungary
View all 15 locations
View Trial Details
Completed

An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

NCT01806298

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +11 more
Locations
  • Research site Adelaide, South Australia, Australia
  • Research site Perth, Western Australia, Australia
  • Research site Clayton, Australia
  • Research site Darlinghurst, Australia
View all 19 locations
View Trial Details

Related conditions